CUI Trademark

Trademark Overview

On Thursday, July 15, 2010, a trademark application was filed for CUI with the United States Patent and Trademark Office. The USPTO has given the CUI trademark a serial number of 85085927. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 8, 2021. This trademark is owned by Pharsight. The CUI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research, namely, evaluating the safety and efficacy tradeoffs in drug profiles through a quantitative and collaborative process
cui

General Information

Serial Number85085927
Word MarkCUI
Filing DateThursday, July 15, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 8, 2021
Registration Number3925628
Registration DateTuesday, March 1, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 14, 2010

Trademark Statements

Goods and ServicesScientific research, namely, evaluating the safety and efficacy tradeoffs in drug profiles through a quantitative and collaborative process
Pseudo MarkCLINICAL UTILITY INDEX

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 8, 2021
Primary Code042
First Use Anywhere DateWednesday, February 4, 2009
First Use In Commerce DateWednesday, February 4, 2009

Trademark Owner History

Party NameCERTARA, L.P.
Party Type31 - New Owner After Registration
Legal Entity Type13 - Limited Partnership
AddressST. LOUIS, MO 63101
Party NamePharsight
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMountain View, CA 940411530
Party NamePharsight
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMountain View, CA 940411530
Party NamePharsight
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMountain View, CA 940411530

Trademark Events

Event DateEvent Description
Friday, October 8, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Wednesday, June 23, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sunday, March 1, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, May 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 23, 2017ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sunday, December 11, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, December 11, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, November 11, 2016TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, November 4, 2016POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Friday, November 4, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 26, 2016TEAS SECTION 8 & 15 RECEIVED
Tuesday, March 1, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 10, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 22, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, September 18, 2013AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 28, 2012ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, March 21, 2012ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, March 1, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, December 14, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 14, 2010PUBLISHED FOR OPPOSITION
Wednesday, November 10, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 10, 2010ASSIGNED TO LIE
Thursday, October 28, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 28, 2010ASSIGNED TO EXAMINER
Wednesday, July 21, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 19, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

through profiles quantitative collaborative process drug tradeoffs namely research evaluating